Impact BioMedical, Inc. (IBO)
0.4596
-0.02
(-4.25%)
USD |
NYAM |
Aug 24, 16:00
0.4596
0.00 (0.00%)
After-Hours: 20:00
Impact BioMedical Market Cap : 49.55M for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 21, 2026 | 51.75M |
| August 20, 2026 | 48.44M |
| August 19, 2026 | 46.71M |
| August 18, 2026 | 50.68M |
| August 17, 2026 | 51.47M |
| August 14, 2026 | 49.52M |
| August 13, 2026 | 47.44M |
| August 12, 2026 | 48.20M |
| August 11, 2026 | 46.36M |
| August 10, 2026 | 46.96M |
| August 07, 2026 | 46.91M |
| August 06, 2026 | 48.61M |
| August 05, 2026 | 46.36M |
| August 04, 2026 | 47.44M |
| August 03, 2026 | 47.33M |
| July 31, 2026 | 46.36M |
| July 30, 2026 | 46.36M |
| July 29, 2026 | 45.99M |
| July 28, 2026 | 46.36M |
| July 27, 2026 | 46.58M |
| July 24, 2026 | 47.44M |
| July 23, 2026 | 46.40M |
| July 22, 2026 | 46.40M |
| July 21, 2026 | 47.55M |
| July 20, 2026 | 47.98M |
| Date | Value |
|---|---|
| July 17, 2026 | 49.17M |
| July 16, 2026 | 49.17M |
| July 15, 2026 | 49.60M |
| July 14, 2026 | 51.75M |
| July 13, 2026 | 49.92M |
| July 10, 2026 | 47.66M |
| July 09, 2026 | 48.79M |
| July 08, 2026 | 48.70M |
| July 07, 2026 | 48.70M |
| July 06, 2026 | 51.43M |
| July 02, 2026 | 50.89M |
| July 01, 2026 | 52.19M |
| June 30, 2026 | 49.60M |
| June 29, 2026 | 54.27M |
| June 26, 2026 | 50.78M |
| June 25, 2026 | 51.32M |
| June 24, 2026 | 53.66M |
| June 23, 2026 | 58.00M |
| June 22, 2026 | 57.37M |
| June 18, 2026 | 54.15M |
| June 17, 2026 | 62.21M |
| June 16, 2026 | 58.84M |
| June 15, 2026 | 59.52M |
| June 12, 2026 | 63.08M |
| June 11, 2026 | 60.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enveric Biosciences, Inc. | 5.550M |
| LENZ Therapeutics, Inc. | 144.52M |
| ANI Pharmaceuticals, Inc. | 1.705B |
| Corcept Therapeutics, Inc. | 13.30B |
| Veru, Inc. | 44.50M |
Market Cap Related Metrics
| PS Ratio | 1091.27 |
| Price to Book Value | 4.603 |
| Price | 0.4596 |
| Earnings Yield | -21.37% |